Liver damage associated with the combination drug amoxicillin-clavulanic acid (Augmentin);Leverbeschadiging in verband met de geneesmiddelencombinatie amoxicilline-clavulaanzuur (Augmentin)

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 26, 1997, Pages 1298-1301

  De Haan, F ^a   Stricker, B H Ch ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Sectie Geneesmiddelenbewaking   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; DRUG USE; FEMALE; HUMAN; LIVER INJURY; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; RISK ASSESSMENT; SYMPTOM;

AMOXICILLIN; CLAVULANIC ACID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 0030794239     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Stricker BHCh. Diagnosis and causality assessment of drug-induced hepatic injury. In: Stricker BHCh, editor. Drug-induced hepatic injury. 2nd ed. Amsterdam: Elsevier, 1992:4-10.
2. Garcia Rodriguez LA, Stricker BHCh, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996;156:1327-32.
3. Hanssens M, Mast A, Maele V van, Pauwels W. Cholestatische icterus door amoxicilline-clavulaanzuur bij 4 patiënten. Ned Tijdschr Geneeskd 1994;138:1481-3.
4. Thomson JA, Fairley CK, Ugoni AM, Forbes AB, Purcell PM, Desmond PV, et al. Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust 1995;162:638-40.
5. Hebbard GS, Smith KGC, Gibson PR, Bhathal PS. Augmentin-induced jaundice with a fatal outcome. Med J Aust 1992;156:285-6.
6. Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel H, et al. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut 1992;33:368-71.
7. Wong FS, Ryan J, Dabkowski P, Dudley FJ, Sewell RB, Smallwood RA. Augmentin-induced jaundice. Med J Aust 1991;154:698-701.
8. Verhamme M, Ramboer C, Bruaene P van de, Inderadjaja N. Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation. J Hepatol 1989;9:260-4.
9. Schneider JE, Kleinman MS, Kupiec JW. Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium. N Y State J Med 1989;89:355-6.
10. Stricker BHCh, Broek JWG van den, Keuning J, Eberhardt W, Houben HGJ, Johnson M, et al. Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin). Dig Dis Sci 1989;34:1576-80.
11. Broek JWG van den, Buennemeyer BLM, Stricker BHCh. Cholestatische hepatitis door de combinatie amoxicilline en clavulaanzuur (Augmentin). Ned Tijdschr Geneeskd 1988;132:1495-7.
12. Ryley NG, Fleming KA, Chapman RW. Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin). J Hepatol 1995;23:278-82.
13. Hautekeete ML, Brenard R, Horsmans Y, Henrion J, Verbist L, Derue G, et al. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 1995;22:71-7.
14. Riemsdijk MM van, Herings RMC, Rawlins MD, Stricker BHCh. Redenen om wel of niet bijwerkingen van geneesmiddelen te melden bij het landelijke meldingssysteem in Nederland. Ned Tijdschr Geneeskd 1995;139:2306-8.